- Home
- AVIR vs MPV Comparison
AVIR vs MPV Comparison
Compare AVIR & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | MPV |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 201.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | MPV |
|---|---|---|
| Price | $6.06 | $18.88 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 580.5K | 11.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $15.41 |
| 52 Week High | $6.45 | $21.00 |
Technical Indicators
Market Signals| Indicator | AVIR | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 76.73 | 49.66 |
| Support Level | $3.33 | $18.74 |
| Resistance Level | N/A | $19.54 |
| Average True Range (ATR) | 0.32 | 0.38 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 79.37 | 63.16 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.